Cell Line : RERF-LC-MS
Cellosaurus Index : CVCL_1655
Cellosaurus ID : RERF-LC-MS
GDSC1 Name
, GDSC2 Name
: RERF-LC-MS
CCLE Name
: RERFLCMS_LUNG
CTRP2 Name
: RERFLCMS
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| RERF-LC-MS | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 17.0000 |
|
| RERF-LC-MS | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| RERF-LC-MS | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | AA-COCF3 | CTRP2 | 0.0010 | 1.0000 |
|
| RERF-LC-MS | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| RERF-LC-MS | Afatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| RERF-LC-MS | AGK-2 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| RERF-LC-MS | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| RERF-LC-MS | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| RERF-LC-MS | Alisertib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| RERF-LC-MS | Alpelisib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| RERF-LC-MS | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| RERF-LC-MS | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| RERF-LC-MS | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| RERF-LC-MS | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| RERF-LC-MS | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | AT7867 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| RERF-LC-MS | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Axitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| RERF-LC-MS | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | AZD1480 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| RERF-LC-MS | AZD4547 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| RERF-LC-MS | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| RERF-LC-MS | AZD6482 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| RERF-LC-MS | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | AZD8055 | GDSC1,CTRP2 | 0.0020 | 33.0000 |
|
| RERF-LC-MS | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| RERF-LC-MS | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| RERF-LC-MS | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| RERF-LC-MS | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| RERF-LC-MS | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| RERF-LC-MS | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| RERF-LC-MS | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Belinostat | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Bexarotene | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BI-2536 | GDSC2,CTRP2 | 0.0005 | 33.0000 |
|
| RERF-LC-MS | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| RERF-LC-MS | Bicalutamide | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| RERF-LC-MS | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | Bleomycin | GDSC1 | 0.2500 | 64.0000 |
|
| RERF-LC-MS | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | Bleomycin (50 uM) | GDSC1 | 0.1953 | 50.0000 |
|
| RERF-LC-MS | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BMS-345541 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BMS-536924 | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | BMS-754807 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Bortezomib | GDSC2,CTRP2 | 0.0000 | 0.1300 |
|
| RERF-LC-MS | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| RERF-LC-MS | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| RERF-LC-MS | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| RERF-LC-MS | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| RERF-LC-MS | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| RERF-LC-MS | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| RERF-LC-MS | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K50799972 | CTRP2 | 0.0020 | 17.0000 |
|
| RERF-LC-MS | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K55116708 | CTRP2 | 0.0020 | 17.0000 |
|
| RERF-LC-MS | BRD-K55473186 | CTRP2 | 0.0020 | 33.0000 |
|
| RERF-LC-MS | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| RERF-LC-MS | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| RERF-LC-MS | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| RERF-LC-MS | BRD4132 | CTRP2 | 0.0049 | 80.0000 |
|
| RERF-LC-MS | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | BRD8899 | CTRP2 | 0.0020 | 33.0000 |
|
| RERF-LC-MS | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| RERF-LC-MS | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| RERF-LC-MS | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | BX795 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Cabozantinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| RERF-LC-MS | canertinib | CTRP2 | 0.0020 | 33.0000 |
|
| RERF-LC-MS | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| RERF-LC-MS | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| RERF-LC-MS | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 25.0000 |
|
| RERF-LC-MS | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| RERF-LC-MS | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | CCT-018159 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| RERF-LC-MS | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| RERF-LC-MS | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| RERF-LC-MS | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| RERF-LC-MS | Cediranib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| RERF-LC-MS | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| RERF-LC-MS | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| RERF-LC-MS | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | CHIR-99021 | GDSC1,GDSC2,CTRP2 | 0.0024 | 80.0000 |
|
| RERF-LC-MS | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| RERF-LC-MS | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| RERF-LC-MS | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| RERF-LC-MS | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Cisplatin | GDSC1 | 0.0117 | 10.0000 |
|
| RERF-LC-MS | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| RERF-LC-MS | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| RERF-LC-MS | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Crizotinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| RERF-LC-MS | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| RERF-LC-MS | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| RERF-LC-MS | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| RERF-LC-MS | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Cytarabine | GDSC1 | 0.0078 | 2.0000 |
|
| RERF-LC-MS | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Dabrafenib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| RERF-LC-MS | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| RERF-LC-MS | Dactolisib | GDSC1,GDSC2,CTRP2 | 0.0003 | 17.0000 |
|
| RERF-LC-MS | Daporinad | GDSC1,GDSC2,CTRP2 | 0.0001 | 2.0000 |
|
| RERF-LC-MS | Dasatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| RERF-LC-MS | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Dinaciclib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| RERF-LC-MS | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| RERF-LC-MS | Docetaxel | GDSC1,GDSC2,CTRP2 | 0.0000 | 66.0000 |
|
| RERF-LC-MS | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| RERF-LC-MS | Doramapimod | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| RERF-LC-MS | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 |
|
| RERF-LC-MS | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| RERF-LC-MS | Entinostat | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| RERF-LC-MS | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| RERF-LC-MS | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Erlotinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| RERF-LC-MS | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| RERF-LC-MS | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| RERF-LC-MS | Etoposide | GDSC1,CTRP2 | 0.0009 | 28.0000 |
|
| RERF-LC-MS | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Fedratinib | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| RERF-LC-MS | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| RERF-LC-MS | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| RERF-LC-MS | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| RERF-LC-MS | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Foretinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | FQI-2 | CTRP2 | 0.0010 | 17.0000 |
|
| RERF-LC-MS | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| RERF-LC-MS | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| RERF-LC-MS | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| RERF-LC-MS | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| RERF-LC-MS | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | GANT-61 | CTRP2 | 0.0020 | 33.0000 |
|
| RERF-LC-MS | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Gemcitabine | GDSC1,GDSC2,CTRP2 | 0.0002 | 33.0000 |
|
| RERF-LC-MS | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| RERF-LC-MS | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| RERF-LC-MS | GSK1059615 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| RERF-LC-MS | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 5.0000 |
|
| RERF-LC-MS | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | GSK269962A | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| RERF-LC-MS | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| RERF-LC-MS | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| RERF-LC-MS | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| RERF-LC-MS | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | HG-5-113-01 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | HG-5-88-01 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| RERF-LC-MS | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | I-BET-762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | Ibrutinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | IC-87114 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | Idelalisib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| RERF-LC-MS | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | IOX2 | GDSC1,GDSC2 | 0.0004 | 0.5000 |
|
| RERF-LC-MS | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| RERF-LC-MS | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| RERF-LC-MS | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| RERF-LC-MS | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| RERF-LC-MS | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| RERF-LC-MS | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| RERF-LC-MS | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| RERF-LC-MS | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| RERF-LC-MS | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 25.0000 |
|
| RERF-LC-MS | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| RERF-LC-MS | JQ1 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| RERF-LC-MS | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| RERF-LC-MS | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| RERF-LC-MS | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| RERF-LC-MS | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | KU-55933 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | KU-60019 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | L-685458 | CTRP2,CCLE | 0.0011 | 37.0000 |
|
| RERF-LC-MS | Lapatinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| RERF-LC-MS | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| RERF-LC-MS | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| RERF-LC-MS | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| RERF-LC-MS | LGK974 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | Linifanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Linsitinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| RERF-LC-MS | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Luminespib | GDSC1,GDSC2 | 0.0003 | 0.2560 |
|
| RERF-LC-MS | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| RERF-LC-MS | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| RERF-LC-MS | marinopyrrole A | CTRP2 | 0.0020 | 33.0000 |
|
| RERF-LC-MS | Masitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| RERF-LC-MS | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| RERF-LC-MS | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | MG-132 | GDSC2,CTRP2 | 0.0006 | 20.0000 |
|
| RERF-LC-MS | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| RERF-LC-MS | MIM1 | GDSC1 | 0.1562 | 40.0000 |
|
| RERF-LC-MS | MIRA-1 | GDSC2,CTRP2 | 0.0020 | 17.0000 |
|
| RERF-LC-MS | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| RERF-LC-MS | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| RERF-LC-MS | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| RERF-LC-MS | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | MK-2206 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| RERF-LC-MS | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| RERF-LC-MS | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| RERF-LC-MS | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| RERF-LC-MS | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| RERF-LC-MS | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| RERF-LC-MS | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| RERF-LC-MS | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Navitoclax | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| RERF-LC-MS | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| RERF-LC-MS | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Nilotinib | GDSC1,GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| RERF-LC-MS | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| RERF-LC-MS | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| RERF-LC-MS | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| RERF-LC-MS | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| RERF-LC-MS | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| RERF-LC-MS | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| RERF-LC-MS | Nutlin-3a | GDSC1,GDSC2,CTRP2,CCLE | 0.0025 | 150.0000 |
|
| RERF-LC-MS | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| RERF-LC-MS | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Obatoclax Mesylate | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Olaparib | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| RERF-LC-MS | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| RERF-LC-MS | OSI-027 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | OSI-930 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| RERF-LC-MS | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| RERF-LC-MS | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| RERF-LC-MS | Oxaliplatin | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | PAC-1 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Paclitaxel | GDSC2,CTRP2,CCLE | 0.0001 | 66.0000 |
|
| RERF-LC-MS | Palbociclib | GDSC1,GDSC2,CCLE | 0.0025 | 8.0000 |
|
| RERF-LC-MS | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Panobinostat | GDSC1,CCLE | 0.0025 | 8.0000 |
|
| RERF-LC-MS | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| RERF-LC-MS | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| RERF-LC-MS | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| RERF-LC-MS | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Pazopanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | PD0325901 | GDSC1,GDSC2,CCLE | 0.0010 | 8.0000 |
|
| RERF-LC-MS | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| RERF-LC-MS | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| RERF-LC-MS | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| RERF-LC-MS | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| RERF-LC-MS | Pevonedistat | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | PF-4708671 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| RERF-LC-MS | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| RERF-LC-MS | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | PHA-793887 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| RERF-LC-MS | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| RERF-LC-MS | PI-103 | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| RERF-LC-MS | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | PIK-93 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | Piperlongumine | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| RERF-LC-MS | pluripotin | CTRP2 | 0.0010 | 17.0000 |
|
| RERF-LC-MS | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | PLX-4720 | GDSC1,GDSC2,CTRP2,CCLE | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| RERF-LC-MS | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| RERF-LC-MS | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| RERF-LC-MS | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| RERF-LC-MS | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| RERF-LC-MS | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| RERF-LC-MS | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | QL-VIII-58 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | QL-XII-61 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | Quizartinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | RAF265 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Rapamycin | GDSC2,CTRP2 | 0.0001 | 33.0000 |
|
| RERF-LC-MS | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| RERF-LC-MS | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| RERF-LC-MS | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| RERF-LC-MS | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| RERF-LC-MS | Ruxolitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| RERF-LC-MS | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| RERF-LC-MS | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| RERF-LC-MS | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| RERF-LC-MS | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | SB505124 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| RERF-LC-MS | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| RERF-LC-MS | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| RERF-LC-MS | Selisistat | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| RERF-LC-MS | Selumetinib | GDSC1,GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| RERF-LC-MS | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| RERF-LC-MS | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| RERF-LC-MS | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| RERF-LC-MS | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| RERF-LC-MS | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| RERF-LC-MS | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| RERF-LC-MS | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| RERF-LC-MS | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| RERF-LC-MS | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| RERF-LC-MS | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| RERF-LC-MS | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| RERF-LC-MS | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Sepantronium bromide | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| RERF-LC-MS | Serdemetan | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| RERF-LC-MS | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| RERF-LC-MS | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| RERF-LC-MS | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| RERF-LC-MS | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| RERF-LC-MS | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| RERF-LC-MS | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | SN-38 | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| RERF-LC-MS | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | SNX-2112 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| RERF-LC-MS | Sorafenib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| RERF-LC-MS | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Sphingosine Kinase 1 Inhibitor II | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| RERF-LC-MS | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | SU11274 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | T-5345967 | CTRP2 | 0.0160 | 530.0000 |
|
| RERF-LC-MS | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| RERF-LC-MS | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Tamoxifen | GDSC1,GDSC2,CTRP2 | 0.0030 | 100.0000 |
|
| RERF-LC-MS | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Tanespimycin | GDSC1,GDSC2,CTRP2,CCLE | 0.0010 | 33.0000 |
|
| RERF-LC-MS | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| RERF-LC-MS | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| RERF-LC-MS | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| RERF-LC-MS | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| RERF-LC-MS | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| RERF-LC-MS | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| RERF-LC-MS | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Tivozanib | GDSC1,CTRP2 | 0.0004 | 13.0000 |
|
| RERF-LC-MS | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| RERF-LC-MS | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | Topotecan | CTRP2,CCLE | 0.0020 | 33.0000 |
|
| RERF-LC-MS | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| RERF-LC-MS | Tozasertib | GDSC2 | 0.0050 | 5.0000 |
|
| RERF-LC-MS | TPCA-1 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Trametinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| RERF-LC-MS | Tretinoin | GDSC1,GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| RERF-LC-MS | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| RERF-LC-MS | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| RERF-LC-MS | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| RERF-LC-MS | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| RERF-LC-MS | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | TW 37 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | UNC0638 | GDSC1,CTRP2 | 0.0010 | 40.0000 |
|
| RERF-LC-MS | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 17.0000 |
|
| RERF-LC-MS | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| RERF-LC-MS | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| RERF-LC-MS | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| RERF-LC-MS | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| RERF-LC-MS | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Veliparib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Venetoclax | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| RERF-LC-MS | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| RERF-LC-MS | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| RERF-LC-MS | Vinblastine | GDSC1 | 0.0004 | 0.1000 |
|
| RERF-LC-MS | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| RERF-LC-MS | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| RERF-LC-MS | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Vorinostat | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| RERF-LC-MS | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| RERF-LC-MS | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| RERF-LC-MS | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | XAV939 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| RERF-LC-MS | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| RERF-LC-MS | XMD11-85h | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| RERF-LC-MS | XMD8-92 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | YK-4-279 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| RERF-LC-MS | YL54 | CTRP2 | 0.0020 | 33.0000 |
|
| RERF-LC-MS | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| RERF-LC-MS | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| RERF-LC-MS | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| RERF-LC-MS | ZG-10 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| RERF-LC-MS | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| RERF-LC-MS | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| RERF-LC-MS | ZSTK474 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC